Scientists track patients for years after pioneering HIV gene treatment
NCT ID NCT02390297
Summary
This study is monitoring 11 people who previously received an experimental gene therapy for HIV. The goal is to check for any long-term safety issues that might appear years after their treatment. Researchers are watching the patients' health and tracking the modified cells in their blood to see how long they last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quest Clinical Research
San Francisco, California, 94115, United States
-
UCLA CARE Center
Los Angeles, California, 90035, United States
Conditions
Explore the condition pages connected to this study.